Prolonged Hypogammaglobulinemia After Rituximab Therapy for Post-Transplant EBV-Lymphoproliferative Disorder Following Hematopoietic Stem Cell Transplantation in Pediatric Patients
Claire Pluchart(Hôpital Robert-Debré), Jean‐Hugues Dalle(Inserm), Frédérique Duquesne(Hôpital Robert-Debré), Karima Yakouben(Délégation Paris 7), Valérie Guérin(Université Laval), Brigitte Lescoeur, Ghislaine Sterkers(Délégation Paris 7), André Baruchel(Hôpital Robert-Debré), Marie Ouachée(Délégation Paris 7), Béatrice Pédron(Hôpital Robert-Debré), E. Seror(Hôpital Robert-Debré)
Cited by 1
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
|Blood|2005|376
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333